Alzheimer’s Drug Demonstrates Good Tolerability Beyond Clinical Trials
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
Tag: early-stage Alzheimer’s management
POPULAR NEWS
-
Saying Goodbye to PGY-6: Pediatric Fellowship Realities
-
Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates
-
Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks
-
New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
